prof. dr. W.H. (Wiek) van Gilst

Head of Experimental Cardiology

Research

Publications
  1. Combinatietherapie heeft een toegevoegde waarde bij vaatziekte: Rivaroxaban en acetylsalicylzuur bij stabiel atherosclerotisch vaatlijden

    Ten Cate, H., Elsman, B., Gilst, van, W., Jong, de, L., van Laarhoven, H., Liem, A. & Warlé, M., 16-Aug-2019, In : Pharmaceutisch Weekblad. 154

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Treating oxidative stress in heart failure: past, present and future

    van der Pol, A., van Gilst, W. H., Voors, A. A. & van der Meer, P., Apr-2019, In : European Journal of Heart Failure. 21, 4, p. 425-435 11 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

    Blood Pressure Lowering Treatment, Mar-2018, In : PLOS MEDICINE. 15, 3, 20 p., 1002538.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

    Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., Gardin, J. M., Hillege, H. L., Ji, F., Kop, W. J., Lau, E. S., Lee, D. S., Sadreyev, R., van Gilst, W. H., Wang, T. J., Zanni, M. V., Vasan, R. S., Allen, N. B., Psaty, B. M., van der Harst, P., Levy, D., Larson, M., Shah, S. J., de Boer, R. A., Gottdiener, J. S. & Ho, J. E., Aug-2018, In : JACC. Heart failure. 6, 8, p. 701-709 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (486) »

View graph of relations

ID: 75368